[ESPR] YoY Quarter Result on 30-Jun-2016 [#Q2]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
04-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- 3.77%
YoY- -13.23%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Revenue 982 0 0 0 0 0 0 -
PBT -54,221 -45,730 -43,337 -14,035 -12,395 -9,238 -6,921 40.90%
Tax 0 0 433 494 337 18 112 -
NP -54,221 -45,730 -43,337 -14,035 -12,395 -9,238 -6,921 40.90%
Tax Rate - - - - - - - -
Total Cost 55,203 45,730 43,337 14,035 12,395 9,238 6,921 41.32%
Ratio Analysis
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
NP Margin -5,521.49 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
EPS -2.01 -1.71 -1.92 -0.62 -0.55 -0.60 -0.47 27.38%
EPS Diluted -2.01 -1.71 -1.92 -0.62 -0.55 -0.60 -0.47 27.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.